Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA–miRNA–mRNA in Colorectal Carcinogenesis

BackgroundCompetitive endogenous RNA (ceRNA) regulation suggested complex network of all transcript RNAs including long noncoding RNAs (lncRNAs), which can act as natural miRNA sponges to inhibit miRNA functions and modulate mRNA expression. Until now, the specific ceRNA regulatory mechanism of lncRNA–miRNA–mRNA in colorectal cancer (CRC) still remains unclear.Materials and MethodsRNA sequencing data of 478 colon adenocarcinoma cases and 41 controls as well as 166 rectum adenocarcinoma cases and 10 controls were obtained from The Cancer Genome Atlas (TCGA) to investigate the significant changes of lncRNAs, miRNAs and mRNAs in colorectal carcinogenesis. The target lncRNAs and mRNAs of miRNAs were predicted by miRWalk. Functional and enrichment analyses were conducted by DAVID database. The lncRNA–miRNA–mRNA interaction network was constructed using Cytoscape.ResultsWe constructed ceRNA regulatory networks including 22 up-regulated lncRNAs, 12 down-regulated miRNAs and 122 up-regulated mRNAs, as well as 8 down-regulated lncRNAs, 43 up-regulated miRNAs and 139 down-regulated mRNAs. The GO enrichment showed that up-regulated genes mainly enriched in biological process including organic anion transport, collagen catabolic process, wound healing, Wnt receptor signalling and in pathways of tyrosine metabolism, taurine and hypotaurine metabolism, melanogenesis and phenylalanine metabolism. For down-regulated genes, significant enrichment was found in biological process of metal ion homeostasis, transmission of nerve impulse, cell–cell signalling, transmembrane transport and in pathways of ABC transporters, neuroactive ligand–receptor interaction, retinol metabolism, nitrogen metabolism and steroid hormone biosynthesis.ConclusionWe identified significantly altered lncRNAs, miRNAs and mRNAs in colorectal carcinogenesis, which might serve as potential biomarkers for tumorigenesis of CRC. In addition, the ceRNA regulatory network of lncRNA–miRNA–mRNA was constructed, which would elucidate novel molecular mechanisms involved in initiation and progression of CRC, thus providing promising clues for clinical diagnosis and therapy.

[1]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[2]  F. Slack,et al.  Non-coding RNA networks in cancer , 2017, Nature Reviews Cancer.

[3]  Lin Zhang,et al.  The role of long noncoding RNAs in cancer: the dark matter matters. , 2018, Current opinion in genetics & development.

[4]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[5]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[6]  Bo Li,et al.  Long noncoding RNA CCAT1 functions as a ceRNA to antagonize the effect of miR-410 on the down-regulation of ITPKB in human HCT-116 and HCT-8 cells , 2017, Oncotarget.

[7]  E. Abdalla,et al.  New paradigm in the management of liver-only metastases from colorectal cancer. , 2007, Gastrointestinal cancer research : GCR.

[8]  Jian Zhao,et al.  The Novel Long Noncoding RNA TUSC7 Inhibits Proliferation by Sponging MiR-211 in Colorectal Cancer , 2017, Cellular Physiology and Biochemistry.

[9]  K. Mimori,et al.  Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer , 2015, British Journal of Cancer.

[10]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[11]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[12]  M. Ni,et al.  Genome-scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma , 2018, Oncology reports.

[13]  Harsh Dweep,et al.  miRWalk database for miRNA-target interactions. , 2014, Methods in molecular biology.

[14]  Fenghua Wang,et al.  Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression , 2017, Theranostics.

[15]  J. Foekens,et al.  CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer , 2013, Genome research.

[16]  O. Slabý,et al.  Therapeutic targeting of non-coding RNAs in cancer. , 2017, The Biochemical journal.

[17]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[18]  Peng Huang,et al.  UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution , 2014, Pathology.

[19]  M. Scheideler,et al.  Long Non-Coding RNAs in Metabolic Organs and Energy Homeostasis , 2017, International journal of molecular sciences.

[20]  P. Pandolfi,et al.  The Epitranscriptome of Noncoding RNAs in Cancer. , 2017, Cancer discovery.

[21]  Junming Guo,et al.  Regulatory mechanisms of long noncoding RNAs on gene expression in cancers. , 2017, Cancer genetics.

[22]  Mari Masuda,et al.  Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer. , 2015, Pharmacology & therapeutics.

[23]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[24]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[25]  D. Glavač,et al.  Long Noncoding RNAs as Biomarkers in Cancer , 2017, Disease markers.

[26]  J. Greenson,et al.  Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis. , 2012, Cancer research.

[27]  A. Bhan,et al.  Long Noncoding RNA and Cancer: A New Paradigm. , 2017, Cancer research.

[28]  Emanuela Felley-Bosco,et al.  Long Noncoding RNAs in Cancer and Therapeutic Potential. , 2017, Advances in experimental medicine and biology.

[29]  Beibei Ni,et al.  Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer. , 2015, International journal of oncology.

[30]  Qiu-yan Wang,et al.  Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis , 2018, OncoTargets and therapy.

[31]  Liuqing Yang,et al.  Long Noncoding RNA in Cancer: Wiring Signaling Circuitry. , 2017, Trends in cell biology.

[32]  F. Slack,et al.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases , 2017, Nature Reviews Drug Discovery.

[33]  Mingyang Song,et al.  MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival , 2016, Clinical Cancer Research.

[34]  Meng Ding,et al.  Correlation analysis between liver metastasis and serum levels of miR‑200 and miR‑141 in patients with colorectal cancer. , 2017, Molecular medicine reports.

[35]  Gene Ontology Consortium,et al.  The Gene Ontology (GO) project in 2006 , 2005, Nucleic Acids Res..

[36]  Nathalia Amado,et al.  Flavonoids and Wnt/β-Catenin Signaling: Potential Role in Colorectal Cancer Therapies , 2014, International journal of molecular sciences.

[37]  Lei Yu,et al.  Investigation of the roles of exosomes in colorectal cancer liver metastasis. , 2015, Oncology reports.

[38]  J. Carethers,et al.  Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer. , 2015, Gastroenterology.

[39]  Jing Zhu,et al.  Overexpression of long non-coding RNA colon cancer-associated transcript 2 is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer. , 2017, Oncology letters.

[40]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .